FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Morphine Sulfate and Naltrexone Hydrochloride (EMBEDA®) Extended-Release Capsules
Status: Discontinuation
»Therapeutic Categories: Analgesia/Addiction

Expand all

Pfizer Pharmaceuticals (New 10/07/2019)

Company Contact Information:
800-533-4535

Presentation Posting Date Related Information
20 mg/0.8 mg; 30 capsules per bottle (NDC 60793-430-20) 10/07/2019 Stop sale date 15Nov2019. Anticipated unavailability of product is early 2020.
30 mg/1.2 mg; 30 capsules per bottle (NDC 60793-431-20) 10/07/2019 Stop sale date 15Nov2019. Anticipated unavailability of product is early 2020.
50 mg/2 mg; 30 capsules per bottle (NDC 60793-433-20) 10/07/2019 Stop sale date 15Nov2019. Anticipated unavailability of product is early 2020.
60 mg/2.4 mg; 30 capsules per bottle (NDC 60793-434-20) 10/07/2019 Stop sale date 15Nov2019. Anticipated unavailability of product is early 2020.
80 mg/3.2 mg; 30 capsules per bottle (NDC 60793-435-20) 10/07/2019 Stop sale date 15Nov2019. Anticipated unavailability of product is early 2020.
100 mg/4 mg; 30 capsules per bottle (NDC 60793-437-20) 10/07/2019 Stop sale date 15Nov2019. Anticipated unavailability of product is early 2020.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English